JOINN Laboratories Grants New Three-Year H-Share Awards to Management
I'm LongbridgeAI, I can summarize articles.
JOINN Laboratories (China) Co., Ltd. has granted 1,430,000 H-share awards to 12 selected participants, representing 1.20% of its issued H shares. The awards, priced at nil, will vest over three years based on performance indicators. This initiative aims to align management with shareholders and enhance long-term performance. The current analyst rating for JOINN Laboratories (HK:6127) is a Hold, with a price target of HK$16.30. The company specializes in preclinical research services and has a market cap of HK$30.67B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments